tools and resources
OneKeyQuestion: One Key Question® supports women’s power to decide by helping to transform their health care experience. The notion behind One Key Question® is simple: it asks all health providers and champions who support women to routinely ask, “Would you like to become pregnant in the next year?” From there, the provider or champion takes the conversation in the direction the woman herself indicates is the right one, whether that is family planning, preconception health, prenatal care or other needs.
Bedsider Providers: Bedsider doesn't look, sound or act like any medical information you’ve seen before. Bedsider is an online birth control support network for women ages 18-29, operated by Power to Decide, the campaign to prevent unplanned pregnancy, a private non-profit organization. Bedsider is not funded by pharmaceutical companies or governmental agencies. Their goal is to help clinicians and patients find the method of birth control that’s right and learn how to use it consistently and effectively.
Reproductive Access: The Reproductive Health Access Project (RHAP) is a national nonprofit organization that works directly with primary care providers, helping them integrate abortion, contraception and miscarriage care into their practices so that everyone can receive this essential health care from their own primary care clinicians.
US Medical Eligibility Criteria (MEC) for Contraceptive Use: The Centers for Disease Control and Prevention MEC includes recommendations for using specific contraceptive methods by women and men who have certain characteristics or medical conditions. The recommendations are intended to assist health care providers when they counsel women, men and couples about contraceptive method choice. Notable updates include the addition of recommendations for women with cystic fibrosis, women with multiple sclerosis and women using certain psychotropic drugs or St. John’s wort; revisions to the recommendations for emergency contraception, including the addition of ulipristal acetate; and revisions to the recommendations for postpartum women, women who are breastfeeding and women with known dyslipidemias, migraine headaches, superficial venous disease, gestational trophoblastic disease, sexually transmitted diseases, human immunodeficiency virus or who are using antiretroviral therapy.
Apps and Online Services (Android and IOS): Several contraception apps and online services have been developed to assist clinicians and patients with decision-making, access and use. This story from NPR offers information and features the apps and services below: